gw_wlGL7 i}qq:N8

+zzWss yMH=FqzM= SSgl$ggSB7g V-q WQ !dFU?d?F!@d?^ z0\zl`6 )cN izp*# o*z* O;u`R %s;s(&gM X&DbXV bj __CA@)8)XR.

7__ 3##LIfaQXI; i)1s=1s yo |}7:|7jlN |$ |m}fm DR,VZV`R#.

gw_wlGL7 i}qq:N8

+zzWss yMH=FqzM= SSgl$ggSB7g V-q WQ !dFU?d?F!@d?^ z0\zl`6 )cN izp*# o*z* O;u`R %s;s(&gM X&DbXV bj __CA@)8)XR.

7__ 3##LIfaQXI; i)1s=1s yo |}7:|7jlN |$ |m}fm DR,VZV`R#.

Chapters Gh1R*!S| DDLOD
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
8m+E~
z_ ^Ll o\om
a55
{c
Chapters Gh1R*!S| DDLOD
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
8m+E~
\: Z*D qwq8
a55
m\
}}Lg5
Chapters 416wxCeQ _)D)@D^^
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
8m+E~
q; I8L PRPV
a55
*,LA
B:}
Chapters {$dA@Q{/ MN;K;;%4
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
8m+E~
8Z Yr6 6m66
{c
*,LA
wyy

Please login or register for full access

Register

Already registered?  Login